Overview
PaNeX: Partial Nephrectomy Under Xenon
Status:
Completed
Completed
Trial end date:
2016-02-01
2016-02-01
Target enrollment:
0
0
Participant gender:
All
All
Summary
Purpose of this study is to determine whether Xenon - as compared to Isoflurane - shows a nephroprotection after partial nephrectomy.Phase:
Phase 3Accepts Healthy Volunteers?
NoDetails
Lead Sponsor:
RWTH Aachen UniversityCollaborator:
German Research FoundationTreatments:
Anesthetics
Isoflurane
Xenon
Criteria
Inclusion Criteria:- Patients willing and able to complete the requirements of this study
- Patients with renal carcinoma restricted to one kidney
- Patients undergoing partial nephrectomy
- Men and women >= 18 yrs
- Informed consent
Exclusion Criteria:
- Chronic renal failure with a GFR < 60ml/min/1,73m2 body surface area
- American Society of Anesthesiologists (ASA)>III
- Hypersensitivity to the study anaesthetics
- Chronic obstructive pulmonary disease (COPD) GOLD IV
- Acute coronary syndrome during the last 24 hours; haemodynamic instability,
requirement of inotropic support
- Severe cardial dysfunction New York Heart Association (NYHA) >III
- Disabling neuropsychiatric disorders
- Increased intracranial pressure
- pregnant or breastfeeding women
- Women of childbearing potential
- Presumed uncooperativeness or legal incapacity
- Lack of informed consent
- Participation in a concomitant trial within the last 30 days